A reflective process led by a family physician to develop a renal-protection surveillance tool for HIV patients newly started on dolutegravir.
Afr J Prim Health Care Fam Med
; 13(1): e1-e3, 2021 Sep 30.
Article
in English
| MEDLINE | ID: covidwho-1463908
ABSTRACT
A group of Vanguard Community Health Centre doctors embarked on a Health System's Improvement (HSI) project with the aim of reducing harm to renal function in patients who were either commenced on or switched to a dolutegravir (DTG)-based antiretroviral therapy (ART) regimen since 2019, when the usual monitoring and evaluation of ART-regimen switches were disrupted by the coronavirus disease 2019 (COVID-19) pandemic. This intended harm-reduction exercise, involving a reflective process that was facilitated by the family physician, led to the development of a Vanguard Renal Protection Surveillance tool, which is now used at Vanguard to detect and prevent renal decline.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
HIV Infections
/
COVID-19
Type of study:
Experimental Studies
Limits:
Humans
Language:
English
Journal:
Afr J Prim Health Care Fam Med
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS